Total (N = 12,056) | Filgrastim (N = 373) | Pegfilgrastim (N = 11,683) | ||
---|---|---|---|---|
All-cause | Hospitalizations n (%)* | 620 (5.1) | 38 (10.2) | 582 (5.0) |
Mean ± SD† | 0.06 ± 0.26 | 0.14 ± 0.46 | 0.05 ± 0.25 | |
Ambulatory visits n (%)* | 12,051 (100) | 373 (100) | 11,678 (100) | |
Mean ± SD† | 5.5 ± 3.7 | 9.5 ± 5.9 | 5.4 ± 3.5 | |
Emergency room visits n (%)* | 943 (7.8) | 27 (7.2) | 916 (7.8) | |
Mean ± SD† | 0.11 ± 0.46 | 0.09 ± 0.32 | 0.11 ± 0.46 | |
Neutropenia- related | Hospitalizations n (%)* | 73 (0.61) | 5 (1.34) | 68 (0.58) |
Mean ± SD† | 0.01 ± 0.08 | 0.02 ± 0.17 | 0.01 ± 0.08 | |
Ambulatory visits n (%)* | 3,422 (28.4) | 148 (39.7) | 3,274 (28.0) | |
Mean ± SD† | 0.42 ± 0.93 | 2.1 ± 3.3 | 0.36 ± 0.68 | |
Emergency room visits n (%)* | 32 (0.27) | 1 (0.27) | 31 (0.27) | |
Mean ± SD† | 0.00 ± 0.05 | 0.00 ± 0.05 | 0.00 ± 0.05 |